Aldo Manzin

5.1k total citations · 1 hit paper
122 papers, 3.8k citations indexed

About

Aldo Manzin is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Aldo Manzin has authored 122 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Epidemiology, 47 papers in Hepatology and 34 papers in Infectious Diseases. Recurrent topics in Aldo Manzin's work include Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (40 papers) and Liver Disease Diagnosis and Treatment (21 papers). Aldo Manzin is often cited by papers focused on Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (40 papers) and Liver Disease Diagnosis and Treatment (21 papers). Aldo Manzin collaborates with scholars based in Italy, Czechia and France. Aldo Manzin's co-authors include Massimo Clementi, Pietro E. Varaldo, Stefano Menzo, Vanessa Palmas, Laura Solforosi, Sarah Vascellari, Fernanda Velluzzi, Andrea Deledda, Roberto Cusano and Mauro Giacca and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Microbiology Reviews.

In The Last Decade

Aldo Manzin

119 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gut microbiota markers associated with obesity and overweight in Italian adults

2021 258 citations Vanessa Palmas, Andrea Deledda et al. profile →

Peers

Countries citing papers authored by Aldo Manzin

Since Specialization

Citations

This map shows the geographic impact of Aldo Manzin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Manzin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Manzin more than expected).

Fields of papers citing papers by Aldo Manzin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Manzin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Manzin. The network helps show where Aldo Manzin may publish in the future.

Co-authorship network of co-authors of Aldo Manzin

This figure shows the co-authorship network connecting the top 25 collaborators of Aldo Manzin. A scholar is included among the top collaborators of Aldo Manzin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aldo Manzin. Aldo Manzin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Liposomal Delivery of a Biotechnological Lavandula angustifolia Miller Extract Rich in Rosmarinic Acid for Topical Herpes Simplex Therapy 2025 ·Antioxidants ·(unknown), Fabrizio Angius, Matteo Perra, Ilenia Delogu, (unknown), Milen I. Georgiev, (unknown), Jana Franková, (unknown), Aldo Manzin, Maria Manconi, María Letizia Manca	1
2	Beyond One-Size-Fits-All: Addressing Methodological Constraints in Novel Antimicrobials Discovery 2025 ·Antibiotics ·(unknown), (unknown), Alessandra Scano, Ilenia Delogu, (unknown), (unknown), Sarah Vascellari, (unknown), Tiziana Pivetta, Guido Ennas, Aldo Manzin, Fabrizio Angius	0
3	Impact of Ketogenic and Mediterranean Diets on Gut Microbiota Profile and Clinical Outcomes in Drug-Naïve Patients with Diabesity: A 12-Month Pilot Study 2025 ·Metabolites ·Vanessa Palmas, Andrea Deledda, Vitor Heidrich, Giuseppina Sanna, (unknown), (unknown), (unknown), (unknown), (unknown), Andrea Loviselli, Aldo Manzin, Fernanda Velluzzi	4
4	Seeking Correlation Among Porin Permeabilities and Minimum Inhibitory Concentrations Through Machine Learning: A Promising Route to the Essential Molecular Descriptors 2025 ·Molecules ·(unknown), (unknown), Ilenia Delogu, Domenica Farci, Dario Piano, Aldo Manzin, Matteo Ceccarelli, Fabrizio Angius, Mariano Andrea Scorciapino, (unknown)	2
5	Exploring the Antiviral Potential of Esters of Cinnamic Acids with Quercetin 2024 ·Viruses ·(unknown), Annalisa Chianese, Vanessa Palmas, (unknown), Carla Zannella, Davide Moi, Francesco Secci, Gabriele Serreli, Giorgia Sarais, (unknown), Massimiliano Galdiero, Valentina Onnis, Aldo Manzin, Giuseppina Sanna	4
6	The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 2024 ·Pathogens ·Giulia Costanzo, Giuseppina Sanna, (unknown), (unknown), Andrea Ledda, Andrea Perra, Vanessa Palmas, (unknown), (unknown), Ferdinando Coghe, Aldo Manzin, Stefano Del Giacco, Luchino Chessa, Davide Firinu	1
7	Physico-Chemical Investigation and Antimicrobial Efficacy of Ozonated Oils: The Case Study of Commercial Ozonated Olive and Sunflower Seed Refined Oils 2024 ·Molecules ·(unknown), Alessandra Scano, Mariano Andrea Scorciapino, (unknown), Sarah Vascellari, Guido Ennas, Aldo Manzin, Fabrizio Angius	9
8	Humoral responses to wild type and ancient BA.1 SARS-CoV-2 variant after heterologous priming vaccination with ChAdOx1 nCoV-19 and BNT162b2 booster dose 2024 ·Clinical and Experimental Medicine ·Giuseppina Sanna, (unknown), Davide Firinu, Cristina Piras, Vanessa Palmas, Massimiliano Galdiero, Luigi Atzori, Paola Caria, Marcello Campagna, Andrea Perra, Giulia Costanzo, Ferdinando Coghe, Roberto Littera, Luchino Chessa, Aldo Manzin	0
9	SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development 2024 ·Vaccines ·Fabrizio Angius, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gualtiero Alvisi, Meng Ling Moi, Aldo Manzin	4
10	Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease 2023 ·Journal of Neurology ·Fabrizio Angius, Ignazia Mocci, Tommaso Ercoli, Francesco Loy, Laura Fadda, (unknown), (unknown), Aldo Manzin, Giovanni Defazio, Anna R. Carta	13
11	Impact of Exposure to Vaccination and Infection on Cellular and Antibody Response to SARS-CoV-2 in CVID Patients Through COVID-19 Pandemic 2023 ·Journal of Clinical Immunology ·Giulia Costanzo, (unknown), Giuseppina Sanna, Andrea Perra, Marcello Campagna, Andrea Ledda, Ferdinando Coghe, Vanessa Palmas, (unknown), Aldo Manzin, Luchino Chessa, Stefano Del Giacco, Davide Firinu	1
12	α-Synuclein seeding activity in duodenum biopsies from Parkinson’s disease patients 2023 ·PLoS Pathogens ·Sarah Vascellari, Christina D. Orrú, Bradley R. Groveman, Sabiha Parveen, Giuseppe Fenu, (unknown), (unknown), Giulia Serra, Valentina Oppo, Daniela Murgia, Andrea Perra, Fabrizio Angius, Andrew G. Hughson, Cathryn L. Haigh, Aldo Manzin, Giovanni Cossu, Byron Caughey	15
13	Hylin-a1: A Pan-Inhibitor against Emerging and Re-Emerging Respiratory Viruses 2023 ·International Journal of Molecular Sciences ·Annalisa Chianese, Carla Zannella, Alessandra Monti, Nunzianna Doti, Giuseppina Sanna, Aldo Manzin, Anna De Filippis, Massimiliano Galdiero	7
14	Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy 2022 ·Journal of Autoimmunity ·Davide Firinu, Giuseppe Fenu, Giuseppina Sanna, Giulia Costanzo, Andrea Perra, Marcello Campagna, Roberto Littera, (unknown), (unknown), (unknown), Maurizio Melis, Germano Orrù, Stefano Del Giacco, Ferdinando Coghe, Aldo Manzin, Luchino Chessa	9
15	Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 2022 ·Vaccines ·Giuseppina Sanna, (unknown), Davide Firinu, Cristina Piras, Gianluigi Franci, Massimiliano Galdiero, (unknown), Vanessa Palmas, Fabrizio Angius, Roberto Littera, Andrea Perra, Germano Orrù, Marcello Campagna, Giulia Costanzo, Federico Meloni, Ferdinando Coghe, Luchino Chessa, Aldo Manzin	5
16	Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets 2022 ·Pharmaceuticals ·Silvia Madeddu, Roberta Ibba, Giuseppina Sanna, Sandra Piras, (unknown), (unknown), (unknown), Paola Caria, Valentina Onnis, Gianluigi Franci, Aldo Manzin, Antonio Carta	3
17	Diet-Derived Antioxidants and Their Role in Inflammation, Obesity and Gut Microbiota Modulation 2021 ·Antioxidants ·Andrea Deledda, Giuseppe Annunziata, Gian Carlo Tenore, Vanessa Palmas, Aldo Manzin, Fernanda Velluzzi	102
18	Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 2021 ·Viruses ·Carla Zannella, Rosa Giugliano, Annalisa Chianese, Carmine Buonocore, Giovanni Andrea Vitale, Giuseppina Sanna, Federica Sarno, Aldo Manzin, Angela Nebbioso, Pasquale Termolino, Lucia Altucci, Massimiliano Galdiero, Donatella de Pascale, Gianluigi Franci	62
19	Molecular epidemiology of TT virus in Italy and phylogenesis of viral isolates from subjects at different risk for parenteral exposure 2001 ·Journal of Medical Virology ·Gianguglielmo Zehender, Aldo Manzin, Chiara De Maddalena, (unknown), Laura Solforosi, (unknown), (unknown), (unknown), (unknown), (unknown), Umberto Russo, Massimo Galli, Massimo Clementi	2
20	Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis 1993 ·IRIS UNIMORE (University of Modena and Reggio Emilia) ·Pietro Andreoné, Carmela Cursaro, Annagiulia Gramenzi, R. Miniero, Aldo Manzin, (unknown), (unknown), Massimo Clementi, G Sprovieri, Antonio Gasbarrini	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact